Company / Goodwill
Ligand Pharmaceuticals, Inc. Goodwill History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$101.5M
FY2025
5-year range
$0 / $105.7M
FY2021-FY2025
Trend
-3.5%
vs FY2024
Sector context
#37 of 74
Health Care
What the data says
At $102M, Ligand Pharmaceuticals, Inc.'s goodwill ranks #37 of 74 in the Health Care sector. Goodwill has fluctuated over the past 10 years, ranging from $0 in FY2022 to $190M in FY2020.
Based on SEC 10-K filings.
$102M in FY2025 with a 5-year CAGR of -11.7%.
Remained stable around $102M over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -11.7%
- 10-Year CAGR
- -
Sector benchmark
#37 of 74 in Health CareTop 50% of 74This company $101.5M Sector average $4.0B
▼
-97.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -11.7%, indicating a declining trend.
- In FY2025, goodwill decreased 3.5% year-over-year.
- Ranks #37 out of 74 companies in the Health Care sector.
- Peak goodwill was recorded in FY2020.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $101.5M | -3.5% |
| FY2024 | $105.3M | +1.8% |
| FY2023 | $103.4M | - |
| FY2022 | $0 | -100.0% |
| FY2021 | $105.7M | -44.3% |
| FY2020 | $189.7M | +99.2% |
| FY2019 | $95.2M | +9.9% |
| FY2018 | $86.6M | +0.8% |
| FY2017 | $86.0M | +19.0% |
| FY2016 | $72.2M | +490.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026